Lexeo Therapeutics, Inc. (LXEO) Revenue (2022 - 2023)
Lexeo Therapeutics' Revenue history spans 2 years, with the latest figure at -$50000.0 for Q4 2023.
- For Q4 2023, Revenue rose 7.41% year-over-year to -$50000.0; the TTM value through Dec 2023 reached -$205000.0, changed N/A, while the annual FY2024 figure was -$137000.0, 33.17% up from the prior year.
- Revenue for Q4 2023 was -$50000.0 at Lexeo Therapeutics, up from -$52000.0 in the prior quarter.
- Across five years, Revenue topped out at $531000.0 in Q3 2022 and bottomed at -$54000.0 in Q4 2022.